live webcast on grant, page-16

Moreld

I likes the part when PC said the grant travelled with BTA. Meaning if some big pharma wants BTA then they get BARDA funding as well.

With Relenza patent expiring in some markets soon. With the Tamiflu issues. With Inavir derisked. With the BTA pipeline looking solid. BTA has got to look very very attractive for still next to nicks.

Market cap today of approx $260 million. 231 non dilutive funding. 80 million cash. Relenza royalities. Inavir royalties. RSV soon to have farm out. HRV licence possiblitites etc.

Whats not to like. Only thing is the stupid aussie market that understand very little of this. A i said time is our friend

Prediction $1.50 plus close today.